{"id":2894,"date":"2021-11-30T10:51:31","date_gmt":"2021-11-30T09:51:31","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2894"},"modified":"2023-09-04T16:15:11","modified_gmt":"2023-09-04T14:15:11","slug":"patents-and-trademarks","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/products\/patents-and-trademarks\/","title":{"rendered":"Patent och varum\u00e4rken"},"content":{"rendered":"

[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.18.0″ _module_preset=”88f366a5-bf49-48d9-a338-ab22706b73e7″ custom_padding_tablet=”” custom_padding_phone=”” global_colors_info=”{}”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_padding=”0px||15px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||||false|false” custom_padding_tablet=”10px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][dipi_breadcrumbs _builder_version=”4.18.0″ _module_preset=”default” max_width=”800px” global_colors_info=”{}”][\/dipi_breadcrumbs][et_pb_divider color=”#EEEEEE” _builder_version=”4.18.0″ _module_preset=”default” max_width=”800px” min_height=”1px” height=”20px” custom_margin=”||3px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.18.0″ _module_preset=”8738c908-7375-4c6c-99a7-9f91f8a3c099″ header_font_size=”56px” max_width=”800px” custom_margin=”||||false|false” global_colors_info=”{}”]<\/p>\n

Patents and Trademarks<\/h6>\n

Patents and Trademarks<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”e9afc0e7-c9bf-4a12-be49-63ddba231101″ custom_margin=”0px||||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.17.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” max_width=”800px” global_colors_info=”{}”]<\/p>\n

– A WIDE PATENT AND TRADEMARK PORTFOLIO PROTECTS ALL OUR PROGRESS<\/h4>\n

\u00a0
AroCell has full ownership of all patents and other intangible assets relating to its products in the field of oncology. AroCell has a strong portfolio as well as several trademarks. To ensure the Group’s opportunities to license products with associated technology and know-how, AroCell works actively to ensure that patents are granted and that trademarks are not used without AroCell’s consent. Our patents cover specific peptide sequences, antibodies and their use. As part of our business model we are actively seeking licensing partners to create mutually advantageous agreements.<\/p>\n

To make our biomarkers available on a large scale, AroCell needs to establish partnerships with in vitro diagnostics companies. By outlicensing the antibodies and technologies that AroCell has to an IVD company, AroCell gets access to a larger market. The large IVD companies have a large number of automated analysis instruments in hospital laboratories and thus a broad customer base. This means that analysis of the biomarkers will be more cost-effective and logistically simpler, which will stimulate clinical use.<\/p>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.17.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.3″ _module_preset=”default” custom_padding=”2px|||||” global_colors_info=”{}”]<\/p>\n

Through an agreement with the patent right holder for the technology for TUBEX\u00ae, IDL Biotech has the exclusive right to global use of the technology. IDL Biotech owns the registered trademark TUBEX\u00ae and the trademarks MonoTotal\u00ae, TPS\u00ae and UBC\u00ae. Company considers that intellectual property protection is sufficient for its operations.<\/p>\n

[\/et_pb_text][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/09\/AroCell-blood-sample.jpeg” title_text=”Hand with blood sample” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Patent no.<\/th>Protection<\/th>Countries<\/th>Status<\/th>Expire date<\/th>\n<\/tr>\n<\/thead>\n
1627230<\/td>Method for use of antibody based test for the prediction of cancer progression - all immuno assays against TK1\t<\/td>DE, ES, FR, GB, IT, SE\t<\/td>Approved<\/td>2024<\/td>\n<\/tr>\n
4668180<\/td>Method for use of antibody based test for the prediction of cancer progression - all immuno assays against TK1\t<\/td>JP<\/td>Approved<\/td>2024<\/td>\n<\/tr>\n
10551385<\/td>Method for use of antibody based test for the prediction of cancer progression - all immuno assays against TK1\t<\/td>US<\/td>Approved<\/td>2024<\/td>\n<\/tr>\n
US 11,959,919<\/td>Method for use of antibody based test for the prediction of cancer progression - all immuno assays against TK1<\/td>US<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
8501419<\/td>Exposed proliferation-related peptides, ligands and methods employing the same<\/td>US<\/td>Approved<\/td>2028<\/td>\n<\/tr>\n
2164954<\/td>Exposed proliferation-related peptides, ligands and methods employing the same<\/td>DE, FR, GB, IT, SE\t<\/td>Approved<\/td>2028<\/td>\n<\/tr>\n
10100128<\/td>Monoclonal antibodies and methods for their use; Ar-1, Ar-2
\nand Ar-3\t<\/td>		US<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
3083698<\/td>Monoclonal antibodies and methods for their use; Ar-1\t<\/td>DE, ES, FR, GB, IT, SE\t<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
3536713<\/td>Monoclonal antibodies and methods for their use; Ar-3<\/td>DE, ES, FR, GB, IT, SE<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
<\/td>Monoclonal antibodies and methods for their use; Ar-2<\/td>EP<\/td>Pending<\/td>2034<\/td>\n<\/tr>\n
105980407\t<\/td>Monoclonal antibodies and methods for their use; Ar-1\t<\/td>CN<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
6715770<\/td>Monoclonal antibodies and methods for their use; Ar-1, Ar-2
\nand Ar-3\t<\/td>		JP<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
<\/td>Predicting survival of prostate cancer\t<\/td>CH, EP, US<\/td>Pending<\/td>2040<\/td>\n<\/tr>\n
<\/td>Respiratory infection detection and classification using TK1\t<\/td>CH, EP, HK, JP, US\t<\/td>Pending<\/td>2040<\/td>\n<\/tr>\n
<\/td>Predicting cancer relapse<\/td>PCT<\/td>Pending<\/td>2041<\/td>\n<\/tr>\n
10386363<\/td>Monototal ELISA - IDL Biotech<\/td>US<\/td>Approved<\/td>2036<\/td>\n<\/tr>\n
105492907<\/td>Monototal ELISA - IDL Biotech<\/td>CN<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
2981823<\/td>Monototal ELISA - IDL Biotech<\/td>FR, GB, DE<\/td>Approved<\/td>2034<\/td>\n<\/tr>\n
1350421-2<\/td>Monototal ELISA - IDL Biotech<\/td>SE<\/td>Approved<\/td>2033<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” global_module=”3323″ saved_tabs=”all” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”51″ disabled_on=”on|on|off” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_menu][et_pb_sidebar area=”et_pb_widget_area_10″ disabled_on=”off|off|on” _builder_version=”4.18.0″ _module_preset=”2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74″ background_color=”#F8F8F8″ locked=”off” global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2365″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.22.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Oncology<\/h6>\n

Diagnostics for oncology<\/h3>\n

Cancer is one of the leading causes of death worldwide, despite advancing knowledge. To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/oncology\/” button_text=”Read more about oncology” _builder_version=”4.22.1″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-sunset.jpeg” title_text=”Happy smiling running beagle dog portrait with tongue out and owner female jogging by the mounting meadow grass path. Walking in nature with pets, happy healthy active people lifestyle concept image.” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n